Startups
2020
OMNISCOPE ESPAÑA SLOne universal diagnostic tool: See what your inmunee system is seeing. Omniscope’s universal diagnostic promises to radically redesign how we detect, diagnose, treat, and monitor diseases.

The results: early detection, unparallelled accuracy and precision for efficient diagnoses, targeted treatments, and minimally invasive monitoring that will dramatically redesign your patient experience and improve health outcomes.
Address
Avinguda Doctor Marañón 8, 08028 Barcelona, Spain
Social Media

CERCA ownership

Other Catalan Public owners

Logo

Status & Deeptech areas

Company Status & Company Deeptech Areas

Current company status

Current company status

DeepTech Area

DeepTech Area

Spinoff information

Company Description

Omniscope was founded in 2020 in response to the global pandemic by a group of scientists who wanted to be of service to humanity at a critical moment for our species. Together, we seek to apply our expertise for immediate impact.

We observed that “modern” medicine was using diagnostic tools that tend to be too narrowly focused - looking only at one disease at a time or focused on specific DNA sequence variations - resulting in diagnostic journeys of time-consuming guesswork. Frustrated that many groundbreaking scientific discoveries stayed in the scientific community instead of helping patients, we were called to find ways to put science in service of humanity and ensure cutting-edge science was accessible to all.

Product description

Our technology is a universal diagnostic tool that scans the immune system through simple, non-invasive clinical tests to broadly detect diseases at the earliest stages. We believe it will truly revolutionize today’s “modern” medicine to be more precise, personalized, and pragmatic, making our healthcare systems more resilient.

‍AI-Powered, High Definition Analytics: Diagnostic precision, accuracy and efficiency to power early detection and targeted treatments.Functionally Integrative: A holistic and personalized picture of overall health to empower patients with actionable information for targeted, early intervention.Simple, Accessible, and

Minimally Invasive: Minimizes patient discomfort and costs through simple clinical tests (i.e. small blood draws). Reduces barriers to treatment through portable, affordable, universally accessible technology.

Cost-Effective: Accessibility and affordability ensure equitable access to cutting-edge medicine, reducing health disparities and % of income spent on healthcare.